Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance.

Montassier E, Batard E, Gastinne T, Potel G, de La Cochetière MF.

Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):841-50. doi: 10.1007/s10096-013-1819-7. Review.

PMID:
23354675
3.

Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact.

Trecarichi EM, Tumbarello M.

Curr Opin Infect Dis. 2014 Apr;27(2):200-10. doi: 10.1097/QCO.0000000000000038. Review.

PMID:
24573013
4.
5.
6.

The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.

Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I, Yaniv I, Shalit I, Samra Z, Pitlik S, Konigsberger H, Weinberger M.

Isr Med Assoc J. 2007 Jun;9(6):424-9.

7.

Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.

Bodro M, Gudiol C, Garcia-Vidal C, Tubau F, Contra A, Boix L, Domingo-Domenech E, Calvo M, Carratalà J.

Support Care Cancer. 2014 Mar;22(3):603-10. doi: 10.1007/s00520-013-2012-3.

PMID:
24170166
9.

Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.

Cumpston A, Craig M, Hamadani M, Abraham J, Hobbs GR, Sarwari AR.

Transpl Infect Dis. 2013 Apr;15(2):142-9. doi: 10.1111/tid.12035.

PMID:
23279656
10.

Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.

Kern WV, Klose K, Jellen-Ritter AS, Oethinger M, Bohnert J, Kern P, Reuter S, von Baum H, Marre R.

Eur J Clin Microbiol Infect Dis. 2005 Feb;24(2):111-8.

PMID:
15714332
11.

Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects.

Velasco E, Byington R, Martins CS, Schirmer M, Dias LC, Gonçalves VM.

Clin Microbiol Infect. 2004 Jun;10(6):542-9.

12.

Bacteremias caused by Escherichia coli in cancer patients - analysis of 65 episodes.

Krcmery V, Spanik S, Mrazova M, Trupl J, Grausova S, Grey E, Kukuckova E, Sulcova M, Krupova I, Koren P.

Int J Infect Dis. 2002 Mar;6(1):69-73.

PMID:
12044306
13.

Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Dalhoff A.

Infection. 2012 Jun;40(3):239-62. doi: 10.1007/s15010-012-0257-2. Review.

PMID:
22460782
14.

Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.

De Rosa FG, Motta I, Audisio E, Frairia C, Busca A, Di Perri G, Marmont F.

BMC Infect Dis. 2013 Dec 1;13:563. doi: 10.1186/1471-2334-13-563.

15.
16.

Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms.

Rangaraj G, Granwehr BP, Jiang Y, Hachem R, Raad I.

Cancer. 2010 Feb 15;116(4):967-73. doi: 10.1002/cncr.24812.

17.

Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen.

Williamson DA, Roberts SA, Paterson DL, Sidjabat H, Silvey A, Masters J, Rice M, Freeman JT.

Clin Infect Dis. 2012 May;54(10):1406-12. doi: 10.1093/cid/cis194.

PMID:
22419681
18.

Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.

Cattaneo C, Quaresmini G, Casari S, Capucci MA, Micheletti M, Borlenghi E, Signorini L, Re A, Carosi G, Rossi G.

J Antimicrob Chemother. 2008 Mar;61(3):721-8. doi: 10.1093/jac/dkm514.

PMID:
18218645
19.

Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.

Cordero L, Rau R, Taylor D, Ayers LW.

Am J Infect Control. 2004 Jun;32(4):189-95.

PMID:
15175611
20.

Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.

Saghir S, Faiz M, Saleem M, Younus A, Aziz H.

Indian J Med Microbiol. 2009 Oct-Dec;27(4):341-7. doi: 10.4103/0255-0857.55454.

Supplemental Content

Support Center